IBIO, INC. Conversion of Stock, Shares Issued
IBIO, INC. (IBIO) reported Conversion of Stock, Shares Issued of 5.89 million shares for the 9-month period ending 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2021-09-28
- IBIO, INC. conversion of stock, shares issued for fiscal 2020 was 5.89M shares, a 138.38% increase from fiscal 2019.
- IBIO, INC. conversion of stock, shares issued for fiscal 2019 was 2.47M shares.
| Period end | Conversion of Stock, Shares Issued 1 month | Conversion of Stock, Shares Issued 8 month | Conversion of Stock, Shares Issued 9 month | Conversion of Stock, Shares Issued 12 month |
|---|---|---|---|---|
| 2021-03-31 | 5.89M shares 10-Q · filed 2021-05-17 | |||
| 2020-08-31 | 28.93M shares 10-Q · filed 2021-05-17 | |||
| 2020-06-30 | 22.55M shares 10-Q · filed 2021-05-17 | 5.89M shares 10-K · filed 2021-09-28 | ||
| 2019-06-30 | 2.47M shares 10-K · filed 2021-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |